Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc.
(OTCEM:KLDO)
Intraday
$0.0001
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0001
0
[0.00%]
At close: Apr 23
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. Stock (OTC:KLDO)
KALEIDO BIOSCIENCES INC by Kaleido Biosciences, Inc. Stock (OTC: KLDO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Sunday, April 17, 2022
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Shanthi Rexaline
-
Apr 17, 2022, 2:31PM
Thursday, April 14, 2022
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Apr 14, 2022, 5:48PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Apr 14, 2022, 1:35PM
shares of low-float penny stock Kaleido Biosciences are trading higher on continued volatility after the company lasts week announced it intends to voluntarily delist its common stock.
Bill Haddad
-
Apr 14, 2022, 1:20PM
Benzinga Pro's Top 5 Stocks To Watch For Thursday, Apr. 14, 2022: TWTR, LI, SFET, NNVC, KLDO
Benzinga Newsdesk
-
Apr 14, 2022, 9:07AM
Wednesday, April 13, 2022
Kaleido Biosciences shares are trading higher on continue volatility after the company last week announced it intends to voluntarily delist its common stock.
Bill Haddad
-
Apr 13, 2022, 1:37PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Apr 13, 2022, 1:35PM
Tuesday, April 12, 2022
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Apr 12, 2022, 5:51PM
Monday, April 11, 2022
Kaleido Biosciences shares are trading lower on continued momentum after the company announced it intends to voluntarily delist its common stock.
Benzinga Newsdesk
-
Apr 11, 2022, 12:36PM
Friday, April 08, 2022
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Apr 8, 2022, 2:00PM
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Apr 8, 2022, 12:35PM
Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why
Vandana Singh
-
Apr 8, 2022, 12:18PM
Kaleido Biosciences Shares Halted Again On Circuit Breaker To Downside; Down 75%
Benzinga Newsdesk
-
Apr 8, 2022, 10:10AM
Kaleido Biosciences Shares Resume Trading, Down 75%
Benzinga Newsdesk
-
Apr 8, 2022, 10:09AM
Kaleido Biosciences Shares Resume Trading, Down 73%
Benzinga Newsdesk
-
Apr 8, 2022, 10:04AM
Kaleido Biosciences Shares Halted On Circuit Breaker To Downside
Benzinga Newsdesk
-
Apr 8, 2022, 9:59AM
Kaleido Biosciences Shares Resume Trading; Down 50%
Benzinga Newsdesk
-
Apr 8, 2022, 9:55AM
Kaleido Biosciences Announces Notice Of Voluntary Delisting Of Common Stock
Benzinga Newsdesk
-
Apr 8, 2022, 9:33AM
Kaleido Biosciences Shares Halted On Code News Pending
Benzinga Newsdesk
-
Apr 8, 2022, 9:20AM
Monday, April 04, 2022
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
Benzinga Insights
-
Apr 4, 2022, 10:04AM
Chardan Capital Downgrades Kaleido Biosciences to Neutral, Lowers Price Target to $1.7
Benzinga Newsdesk
-
Apr 4, 2022, 8:47AM
Friday, March 11, 2022
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Mar 11, 2022, 4:32PM
Friday, February 25, 2022
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Feb 25, 2022, 8:10AM
Friday, February 04, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Feb 4, 2022, 12:54PM
Thursday, February 03, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Feb 3, 2022, 10:49AM
Monday, January 31, 2022
Chardan Capital Maintains Buy on Kaleido Biosciences, Lowers Price Target to $3
Benzinga Newsdesk
-
Jan 31, 2022, 9:24AM
Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target
Vandana Singh
-
Jan 31, 2022, 5:40AM
Tuesday, January 25, 2022
Kaleido Biosciences Granted U.S. Patent #11,229,660 'Glycan therapeutics and method of treating conditions associated with TMAO'
Charles Gross
-
Jan 25, 2022, 9:19AM
Tuesday, January 18, 2022
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jan 18, 2022, 12:42PM
Tuesday, January 11, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Jan 11, 2022, 10:38AM
Thursday, January 06, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Jan 6, 2022, 12:14PM
Friday, December 31, 2021
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Dec 31, 2021, 12:41PM
Thursday, December 30, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 30, 2021, 4:43PM
Thursday, December 16, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Dec 16, 2021, 6:03PM
Monday, December 06, 2021
Kaleido Biosciences Announces Expansion Of Collaboration With Janssen To Explore Potential Of Microbiome Metabolic Therapies To Prevent Childhood-Onset Of Atopic, Immune And Metabolic Conditions
Benzinga Newsdesk
-
Dec 6, 2021, 7:38AM
Monday, November 15, 2021
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Nov 15, 2021, 8:17AM
Friday, November 12, 2021
Chardan Capital Maintains Buy on Kaleido Biosciences, Lowers Price Target to $11
Benzinga Newsdesk
-
Nov 12, 2021, 7:24AM
Wednesday, November 03, 2021
JMP Securities Maintains Market Outperform on Kaleido Biosciences, Lowers Price Target to $22
Benzinga Newsdesk
-
Nov 3, 2021, 7:56AM
Monday, November 01, 2021
Kaleido Biosciences's Return On Capital Employed Insights
Benzinga Insights
-
Nov 1, 2021, 12:06PM
Kaleido Biosciences Q3 EPS $(0.54) Up From $(0.65) YoY, Sales $104.00K Down From $482.00K YoY
Benzinga Newsdesk
-
Nov 1, 2021, 7:32AM
Tuesday, October 19, 2021
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
Benzinga Insights
-
Oct 19, 2021, 10:02AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Oct 19, 2021, 8:08AM
Morgan Stanley Downgrades Kaleido Biosciences to Underweight, Announces $3 Price Target
Benzinga Newsdesk
-
Oct 19, 2021, 7:02AM
Friday, October 08, 2021
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Shanthi Rexaline
-
Oct 8, 2021, 7:31AM
Thursday, October 07, 2021
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Shanthi Rexaline
-
Oct 7, 2021, 8:23AM
Wednesday, October 06, 2021
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Shanthi Rexaline
-
Oct 6, 2021, 7:33AM
36 Biggest Movers From Yesterday
Lisa Levin
-
Oct 6, 2021, 5:44AM
Tuesday, October 05, 2021
Why Did Kaleido Shares Plunge 10% On Tuesday?
Vandana Singh
-
Oct 5, 2021, 4:11PM
Mid-Afternoon Market Update: Dow Jumps 450 Points; Comtech Telecommunications Shares Slide
Lisa Levin
-
Oct 5, 2021, 2:30PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Oct 5, 2021, 2:02PM
Show more